Search Results Search Sort by RelevanceMost Recent Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.